ES2150553T3 - Solucion inyectable de fluoruro de benzalconio. - Google Patents

Solucion inyectable de fluoruro de benzalconio.

Info

Publication number
ES2150553T3
ES2150553T3 ES95907688T ES95907688T ES2150553T3 ES 2150553 T3 ES2150553 T3 ES 2150553T3 ES 95907688 T ES95907688 T ES 95907688T ES 95907688 T ES95907688 T ES 95907688T ES 2150553 T3 ES2150553 T3 ES 2150553T3
Authority
ES
Spain
Prior art keywords
pct
fluoride
benzalconium
injection solution
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95907688T
Other languages
English (en)
Inventor
Pierre Lagny
Pierre Bourbon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aromafarm Ltd
Original Assignee
Aromafarm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aromafarm Ltd filed Critical Aromafarm Ltd
Application granted granted Critical
Publication of ES2150553T3 publication Critical patent/ES2150553T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/16—Fluorine compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Inorganic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Apparatuses For Bulk Treatment Of Fruits And Vegetables And Apparatuses For Preparing Feeds (AREA)
  • Harvesting Machines For Root Crops (AREA)
  • External Artificial Organs (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)

Abstract

LA INVENCION SE REFIERE A UNA SOLUCION ADMINISTRABLE POR VIA INTRAVASCULAR QUE COMPRENDE DEL ORDEN DE AL MENOS DE 0,23% EN PESO DE AL MENOS UN FLUORURO DE BENZALCONIO DISUELTO EN UN EXCIPIENTE INYECTABLE POR VIA INTRAVASCULAR. TIENE APLICACION EN EL TRATAMIENTO DE LAS ENFERMEDADES VIRALES O INFECCIOSAS, PARTICULARMENTE ENFERMEDADES INMUNODEFICIENTES.
ES95907688T 1994-01-24 1995-01-23 Solucion inyectable de fluoruro de benzalconio. Expired - Lifetime ES2150553T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9400695A FR2715300B1 (fr) 1994-01-24 1994-01-24 Solution injectable de fluorure de benzalkonium et application à titre d'antiviral ou d'anti-infectieux.

Publications (1)

Publication Number Publication Date
ES2150553T3 true ES2150553T3 (es) 2000-12-01

Family

ID=9459299

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95907688T Expired - Lifetime ES2150553T3 (es) 1994-01-24 1995-01-23 Solucion inyectable de fluoruro de benzalconio.

Country Status (13)

Country Link
US (1) US5798391A (es)
EP (1) EP0732918B1 (es)
AT (1) ATE194075T1 (es)
AU (1) AU1580695A (es)
BR (1) BR9506639A (es)
CA (1) CA2181885A1 (es)
DE (1) DE69517672T2 (es)
ES (1) ES2150553T3 (es)
FR (1) FR2715300B1 (es)
RU (1) RU2128507C1 (es)
UA (1) UA39970C2 (es)
WO (1) WO1995019766A1 (es)
ZA (1) ZA95483B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2771637B1 (fr) * 1997-12-01 2003-10-24 Hutchinson Utilisation d'un halogenure de dialkyldialkylammonium par voie parenterale dans les infections bacteriennes et virales
DE19918324A1 (de) * 1999-04-22 2000-10-26 Mann Gerhard Chem Pharm Fab Pharmazeutische Zusammensetzung wirksam gegen durch Bakterien, Viren, Pilze, Hefen und Protozoen verursachte Krankheitszustände
US7968122B2 (en) * 2003-12-10 2011-06-28 Adventrx Pharmaceuticals, Inc. Anti-viral pharmaceutical compositions
RU2529790C2 (ru) * 2012-11-26 2014-09-27 Игорь Иванович Марков Способ получения алкилбензилдиметиламмонийфторидов, обладающих противовирусным и антибактериальным действием

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4330551A (en) * 1980-08-26 1982-05-18 Synergetics Co. Therapeutic method
FR2620698B1 (fr) * 1987-09-23 1990-08-10 Atlantic Pharma Prod Fluorure d'ammonium quaternaire et son application dans une substance inhibitrice ou destructrice d'etres vivants unicellulaires

Also Published As

Publication number Publication date
EP0732918B1 (fr) 2000-06-28
AU1580695A (en) 1995-08-08
UA39970C2 (uk) 2001-07-16
DE69517672D1 (de) 2000-08-03
FR2715300A1 (fr) 1995-07-28
ZA95483B (en) 1996-03-20
DE69517672T2 (de) 2001-03-01
CA2181885A1 (fr) 1995-07-27
WO1995019766A1 (fr) 1995-07-27
FR2715300B1 (fr) 1996-03-29
ATE194075T1 (de) 2000-07-15
EP0732918A1 (fr) 1996-09-25
RU2128507C1 (ru) 1999-04-10
BR9506639A (pt) 1997-09-16
US5798391A (en) 1998-08-25

Similar Documents

Publication Publication Date Title
MY132056A (en) Methods of inhibiting physiological conditions associated with an excess of neuropeptide y.
LU91943I2 (fr) Tafluprost et ses dérivés pharmaceutiquement acceptables (SAFLUTAN®)
GR850126B (es)
KR970707139A (ko) 평활근 세포 증식의 억제제로서의 다음이온성 벤질글리코사이드(Polyanionic benzylglycosides as inhibitors of smooth muscle cell proliferation)
KR920021523A (ko) 신규한 우레아 유도체, 이의 제조 방법 및 이들을 함유하는 약제학적 조성물
RU94044490A (ru) Применение 2-фенил-3-ароилбензотиофенов для подавления дефектного восстановления ткани
RU94044454A (ru) Ингибитор аутоимунных заболеваний
ES2100222T3 (es) Derivados del acido aminoalcansulfonico y compuestos farmaceuticos a utilizar para prevenir o tratar afecciones cardiacas.
RU94037233A (ru) Применение 2-фенил-3-ароилбензотиофенов для лечения лекарственноустойчивых новообразований
NO944925L (no) Fremgangsmåte for å öke libido i post-menopausale kvinner
ES2150553T3 (es) Solucion inyectable de fluoruro de benzalconio.
NO944931L (no) Anvendelse av 2-fenyl-3-aroylbenzotiofener for inhibering av tidlig seksuell modenhet
GB2251616B (en) Therapeutic benzazapine compounds
IE821258L (en) Anti-herpes medicaments
HU903092D0 (en) Process for the preparation of buten-carboxylic acid derivatives and pharmaceutical compositions containing such compounds
ES8507468A1 (es) Procedimiento de obtencion de agentes de beta-bloqueantes conteniendo grupos ester con propiedades oftalmologicas
KR950702544A (ko) 비페닐메탄 유도체 및 이를 함유하는 약제
MX9206930A (es) Nuevos compuestos
ATE16383T1 (de) Neue heteroaryloxypropanolamine, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
NO930739L (no) Substituerte fenylkinazolinderivater
SE8500964D0 (sv) Aminodiaryl sulfoxide derivatives, process for their preparation and pharmaceutical and pesticidal compositions containing them
EA199800177A1 (ru) Способ снижения количества экзогенного инсулина, вводимого пациенту с инсулиннезависимым сахарным диабетом
KR960703924A (ko) 항바이러스제로서 신규한 벤조티오펜 유사체(Novel Benzothiophene Analogs as Antiviral Agents)
MY108455A (en) Therapeutic benzazapine compounds.
SE7902264L (sv) N,n'-bis(fenylkarbamoylmetyl)amidiner och sett for framstellning derav

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 732918

Country of ref document: ES